sarpogrelate has been researched along with nitroglycerin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, M; Hanada, H; Kinugawa, T; Lee, JD; Miyamoto, S; Nakajima, H | 1 |
Chayama, K; Goto, C; Higashi, Y; Miyazaki, M; Orihashi, K; Sanada, H; Sueda, T; Yoshizumi, M | 1 |
1 trial(s) available for sarpogrelate and nitroglycerin
Article | Year |
---|---|
Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arterial Occlusive Diseases; Biomarkers; Endothelium, Vascular; Female; Follow-Up Studies; Forearm; Humans; Hyperemia; Leg; Male; Nitroglycerin; Peripheral Vascular Diseases; Regional Blood Flow; Research Design; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates; Time Factors; Treatment Outcome; Vasodilator Agents | 2007 |
1 other study(ies) available for sarpogrelate and nitroglycerin
Article | Year |
---|---|
Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Collateral Circulation; Coronary Angiography; Drug Therapy, Combination; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Nitroglycerin; Serotonin Antagonists; Succinates; Treatment Outcome | 2002 |